I share Senator Murray's concern with regard to the fact that with the FDA, as the agency has grown with large new requirements to publish regulations for food, tobacco, other things, we have seen additional delays in getting guidances and regulations necessary for medical product innovation and the public health finalized and approved.
Roberts expresses concern about FDA delays affecting medical product innovation.
Share
More from Pat Roberts
I am deeply concerned about the impact that today's retaliatory tariffs are having on U.S. agricultural products.
Orrin Hatch is not most people. Simply put, the institution he truly loves will not be the same without him.
His brand of unconditional cordiality is increasingly rare, and this institution sure could use a lot more of it.
Other voices in this conversation
